79279654 - RIBOMIC

Information

• Trademark
• 79279654

• Source

• Serial Number

  79279654

• Registration Number

  6213624

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 09, 2019
  5 years ago

• Registration Date

  December 08, 2020
  4 years ago

• Transaction Date

  April 04, 2021
  4 years ago

• Status Date

  December 08, 2020
  4 years ago

• Published for Opposition Date

  September 22, 2020
  4 years ago

• Location Date

  December 08, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LEE, YAT SYE I

• Attorney Docket Number

  610.094-319

  Attorney Name

  Keith R. Obert

  Law Office Assigned Location Code

  L70

• Owners

  • RIBOMIC INC.

Case File Statements

• CC0000: The color(s) blue and gray is/are claimed as a feature of the mark.
• DM0000: The mark consists of the wording "RIBOMIC" displayed on a partially blue background. The letters "RIB" and "MIC" are in blue and the letter "O" is in gray. The color white represents background or transparent areas and is not a part of the mark.
• GS0011: Chemicals for use in stabilization of RNA before purification and after purification under laboratory experiment and medical examination; chemical reagents for separating, detecting, measuring and analyzing proteins; ribonucleic acid (RNA) for laboratory use; nuclease for scientific or laboratory purposes; unsticking and separating preparations for scientific or laboratory purposes; chemicals for use in industry and science; artificial sweeteners; reagents for medical research
• GS0051: Reagents for medical purposes or medical reagents for diagnostic purposes; chemical preparations for pharmaceutical or medical purposes, namely, for treating vision failure, hearing failure, bone growth failure, lung failure, heart failure, articular failure, mental disorders, central nervous system disorder, blood disorders, skin disorders, pain, inflammation, kidney failure, liver failure, fibrosis, metabolic disorders, endocrine diseases, gynecological diseases, respiratory diseases, cardiovascular diseases, tissue regeneration and cancer; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for preventing and treating infectious diseases; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; reagent paper for medical purposes; gauze for dressings; capsules sold empty for pharmaceuticals; adhesive plasters for medical purposes; dental materials, namely, implants comprising living tissues; dietary supplements for humans
• GS0421: Testing, inspecting, analyzing, surveying, and research and development relating to pharmaceuticals; testing, inspecting or researching of medical technologies, and providing information and consultancy services relating thereto; research and development of pharmaceuticals and medical supplies; providing information relating to research of pharmaceuticals and medical supplies; testing, inspecting or researching of chemicals for medical use; quality evaluation and analysis of functions of chemical compositions available for medical purposes; providing information on medical researches; DNA analysis services for scientific research purposes; cytogenetic testing for scientific research purposes; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing temporary use of on-line non-downloadable computer programs for drug candidate discovery tools on data networks; designing of machines, apparatus, instruments including their parts or systems composed of such machines, apparatus and instruments; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research in the field of machines, apparatuses and instruments in the field of detection of trace components, hazardous substances and microorganisms

Case File Event Statements

• 4/4/2021 - 4 years ago

  28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 3/11/2021 - 4 years ago

  27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 3/11/2021 - 4 years ago

  26 - FINAL DISPOSITION PROCESSED Type: FIMP

• 3/8/2021 - 4 years ago

  25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 12/8/2020 - 4 years ago

  24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 9/22/2020 - 4 years ago

  23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/22/2020 - 4 years ago

  22 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/18/2020 - 4 years ago

  21 - REFUSAL PROCESSED BY IB Type: RFNP

• 9/2/2020 - 4 years ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/20/2020 - 4 years ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/20/2020 - 4 years ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/20/2020 - 4 years ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/20/2020 - 4 years ago

  16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/18/2020 - 4 years ago

  15 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/18/2020 - 4 years ago

  14 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/18/2020 - 4 years ago

  13 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/27/2020 - 4 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/27/2020 - 4 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/27/2020 - 4 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/10/2020 - 5 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 3/23/2020 - 5 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/23/2020 - 5 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/6/2020 - 5 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/3/2020 - 5 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/2/2020 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/2/2020 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/2/2020 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 2/27/2020 - 5 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR